Idun Pharmaceuticals
San Diego · Founded 1993
About Idun Pharmaceuticals
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.
Company Facts
- Founded: 1993
- Legal name: Idun Industrier AB
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $52.9M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2015)
- Website: idun.comsv
Social Profiles
Canonical: https://fsome.com/organization/idun-pharmaceuticals-8435477 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.